We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




RFA Eases Symptoms of Inoperable Lung Cancer

By HospiMedica staff writers
Posted on 22 Nov 2004
A pair of studies has shown that radiofrequency ablation (RFA), guided by computed tomography (CT), is effective in easing the symptoms of inoperable lung cancer, while changes in the size of the tumor as shown on CT determines whether that ablation was successful.

Researchers from S. More...
Sebastiano Hospital (Caserta, Italy) analyzed 33 patients with malignant lung cancer who could not undergo surgery and opted for CT-guided RFA instead. No major complications occurred and all sessions were deemed successful at follow-up CT.

The study was prompted by the feeling that an alternative to the usual therapies for lung cancer was strongly needed. "We see too many lung cancer patients who, inoperable for a number of different reasons, are left with few chances to obtain an effective palliation,” noted lead author Guiseppe Belfiore, M.D. "For sure, RFA allows a better quality of life for many inoperable patients.”

In the second study, researchers from National University Hospital (Chonbuk, South Korea) determined that pattern enhancement--a difference in contrast between a tumor and the surrounding tissue--and changes in tumor size were the most important factors in judging the success of RFA for lung tumors on CT. They analyzed 21 patients who had undergone CT-guided RF, nine who had complete ablations and 12 who had partial ablations. For the former group, the researchers found tumors were without any enhancement on short-term follow-up CT and that the size of the lesions had decreased by 40% after 12 months. For the partially ablated group, the tumors were enhanced to various degrees short-term and the tumor size had increased after six months.

The studies were published in the October 2004 issue of the American Journal of Roentgenology.




Related Links:
Chonbuk National University Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Medical Adhesive
MED 5570U
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.